Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Tag Archives: or

Prior Experience and the Growth of the Biosimilars Mark...
March 1, 2014 - Featured , In the News / Politics

By: Davidta Brown, Senior Staff Editor – In 21st century medicine, pharmaceuticals have come to include compounds derived through novel and complex methods. Some of the most recent innovations have been in the form of biologics, therapeutic compounds produced through biological processes.1 Biologics are derived from living cell lines which may be bacterial, yeast, animal,…

The Status of Surveillance of Japanese Encephalitis in ...
March 1, 2014 - Featured , In the News / Politics

By: Sabrina Ahmed, PharmD Candidate c/o 2017 – One recent stride towards combating worldwide infectious disease has been in the improved surveillance of Japanese encephalitis in Asia, predominantly in South and South-East Asia. This potentially deadly virus is transmitted to humans via mosquito bites. The Japanese encephalitis (JE) virus is the leading cause of encephalitis…

Methadone Associated Arrhythmias on the Rise...
March 1, 2014 - In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Methadone maintenance therapy is prescribed for opioid dependency. Many HIV patients who were former injection drug abusers rely on methadone maintenance. Although there is limited data, research suggests lamivudine, ritonavir, and zidovudine to be the most common concomitant drugs in methadone associated torsades and prolonged QT interval.1…

Dietary Supplements and Their Potential Dangers...
March 1, 2014 - Professional Advice / Opinions

By: Fatema Elias, Staff Writer – With the New Year and everyone committing to their New Year resolutions, more and more patients are coming into the pharmacy asking for recommendations, particularly for weight loss dietary supplements. I hesitate to recommend an over-the-counter dietary supplement for weight loss. However, we as pharmacists and pharmacy students have…

The Importance of Organ Donation: Perspectives and the ...
March 1, 2014 - Featured , Professional Advice / Opinions

By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica Melore and Jennifer McDermott, PharmD, BCPS of NewYork-Presbyterian Hospital – Jessica Melore was 16 years old, a senior in high school, and co-captain of the tennis team when her life took a drastic turn. While…

A Brave New World for Lipid Management...
March 1, 2014 - Featured , In the News / Politics

By: Amrita Singh, PharmD Candidate c/o 2015 – Last November, the American College of Cardiology and the American Heart Association released new lipid guidelines, which will transform the way we manage our patients with hyperlipidemia. Earlier, lipid management was based on the ATP-III guidelines, which emphasized the use of several lipid-lowering medications to reach target…

Going International...
March 1, 2014 - Events

By: Hayeon Na, Co-Copy Editor (Content-focused) – On Tuesday, February 4th, the New Jersey Pharmacist Association (NJPhA) and Dr. Maria Leibfried hosted a seminar for international pharmacy students at St. John’s University. The seminar was held to provide information to international students, especially for those who are here as F-1 students, about their options when…

Psychiatric Prescriptions in the Fight Against Juvenile...
March 1, 2014 - Clinical , Featured

By: Davidta Brown, Senior Staff Editor – In August 2013, the results of a yearlong safety study were published in the Journal of American Medical Association (JAMA) Psychiatry.1 The study, which followed the health status of about 43,000 youths aged 6 to 24, confirmed and built upon a previously noted trend in adults: that the…

To Defend the People...
February 1, 2014 - Featured , Professional Advice / Opinions

By: Davidta Brown, Senior Staff Editor – As the world’s largest market for pharmaceuticals, the United States receives many medications manufactured abroad.1 Patients, physicians, and pharmacists defer the responsibility of ensuring the quality of these imported drugs to the FDA, but it only takes one report of deceit in the pharmaceutical industry for this trust…

Long Term PPI Use Heightens Concern of Associated Healt...
February 1, 2014 - Clinical , Featured

By: Tamara Yunusova, Senior Staff Editor – Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the treatment and prophylaxis of conditions such as peptic ulcer diseases, H. Pylori infection, Zollinger-Ellison syndrome, GERD, and NSAID gastroduodenal ulcers. Their versatility in treating a wide range of conditions, unparalleled efficacy over their Histamine-2-receptor antagonist…

A Walk To Remember...
February 1, 2014 - Events

By: Caitie Stehling, PharmD Candidate c/o 2015 – St. John’s University is grounded in its Catholic, Vincentian, and Metropolitan mission. Students from all different colleges take pride in being able to give back to society. This year, Phi Lambda Sigma, the Pharmacy Leadership Society (PLS), participated in the Alzheimer’s Walk at Corona Park in Queens.…

Low Literacy and Medication Management?...
February 1, 2014 - Professional Advice / Opinions

By: Jenny Park, Pharm. D. Candidate c/o 2015 – As the Affordable Care Act brings health care to many people who are currently uninsured, healthcare providers should expect an increase in the number of patients who don’t understand their plan, disease states, and medications. Health literacy is defined as “the degree to which individuals have…

The Increasing Roles of Pharmacists in Transplant Outco...
February 1, 2014 - Featured , In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Medication adherence is a big part of a patient’s success in managing their health conditions. The Annals of Internal Medicine estimated that the cost of medication non-adherence may reach up to $289 billion each year.1 It is crucial for organ transplant patients to take powerful immunosuppressants to…

Dengue Fever: Where Do We Go From Here?...
February 1, 2014 - In the News / Politics

By: Sherin Pathickal, PharmD Candidate c/o 2016 – Dengue Fever, widely known as “break-bone fever,” is an illness that causes pain in the joints and muscles, and is often described by those infected as comparable to the feeling of breaking a bone.1 It is spread by mosquitoes and has a painful array of symptomology such…

Pharmacy Across the Border: An Interview with Sherif Gu...
February 1, 2014 - Featured , Professional Advice / Opinions

By: Sang Hyo Kim, Staff Editor – For the brand new year, we present an interview with Sherif Guorgui, the current Vice-President of Pharmacy at the Ontario Pharmacists Association and the former 2011-2012 President of the Ontario College of Pharmacists in Canada. Mr. Guorgui graduated in 1998 from the Faculty of Pharmacy at the University…

Dr. Robert Mangione – From Student to Provost of ...
January 1, 2014 - Featured , Professional Advice / Opinions

By: Katharine Cimmino, Editor-in-Chief and Melissa Roy, Co-Copy Editor [Graphics-Focused] – Dr. Mangione has been a prominent member here at St. John’s University both as a student and as a leader. Before becoming our dedicated Provost, Dr. Mangione was the Dean of the College of Pharmacy and Health Sciences since 1999. He joined the St.…

Do You Know Your Organizations?: PLS...
January 1, 2014 - Events

Phi Lambda Sigma (PLS) is a nationally recognized Pharmacy Leadership Society. As the St. John’s Xi Chapter, our organization acknowledges pharmacy students for their leadership in school and in their communities. We provide support for members to become effective leaders as they transition into their careers. We work to foster leadership development in some of the…

Surviving APPE Rotations...
January 1, 2014 - Professional Advice / Opinions

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 – Starting your rotations in 5th year usually brings mixed emotions. On one hand, it’s a relief to finally be finished with labs and D&Ds…imagine, a whole year without any exams! But on the other hand, now you have to test how…

New Alternative First Line Therapy for EGFR NSCLC...
January 1, 2014 - In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new first-line treatment for patients with late-stage non-small cell lung cancer (NSCLC), a type of carcinoma where specific types of epidermal growth factor receptor (EGFR) gene mutations are expressed.1 The drug afatinib irreversibly blocks EGFR, also…

New Hepatitis C Drug Receives FDA Approval...
January 1, 2014 - Clinical , Featured

By: Ada Seldin, Staff Editor – On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C, received approval under the FDA’s priority review program. Simeprevir is an NS3/4A protease inhibitor that blocks the replication of the hepatitis C virus. Two other drugs from the same class, boceprevir and telaprevir, which were…

The Use of Methadone in Neuropathic Pain...
January 1, 2014 - Clinical

By: Neal Shah, PharmD, MD/PhD Student c/o 2021, West Virginia University School of Medicine – Methadone is a powerful long-acting mu-opioid agonist that has been traditionally used in the management of chronic pain, treatment of pain refractory to certain opioid agents, and maintenance of opioid addiction.1-5 While neuropathic pain is not traditionally linked to mu-opioid…

Asperger Syndrome: Temple Grandin’s Insight and Contr...
January 1, 2014 - Events

By: Sang Hyo Kim, Staff Editor – During the Fall 2013 semester, activist and bestselling author Temple Grandin, Ph.D, came to St. John’s University to talk to students, faculty, and administrators about the need to embrace children and young adults who have autism spectrum disorders (ASDs). While many people may think of autism as a…

Do You Know Your Organizations?: PDC...
January 1, 2014 - Events

Phi Delta Chi (PDC) is a national professional Pharmacy fraternity, which has been on the St. John’s University campus since 1958. Phi Delta Chi works with many other organizations to advance the science of pharmacy and allied interests both on and off campus. The brothers of Phi Delta Chi have hosted and attended many events,…

Say Hello to JNC8: New Hypertension Guidelines...
January 1, 2014 - Featured , In the News / Politics

By: Frances Trosa PharmD Candidate c/o 2015 – After much anticipation, the report from the Eighth Joint National Committee (JNC 8) has arrived! Panel members appointed to the committee have created evidence – based recommendations to assist physicians in managing hypertensive patients. A major difference between the JNC 7 report and the JNC 8 report…

Do You Know Your Organizations?: LKS...
January 1, 2014 - Events

      Lambda Kappa Sigma (LKS) is an international professional pharmacy fraternity that provides opportunities to women in pharmacy through professional excellence and personal growth. It was founded at the Massachusetts College of Pharmacy and Health Sciences in 1913, and has grown to over 24,000 members since its inception. Our St. John’s University Alpha…

The Blunt Truth...
January 1, 2014 - Featured , In the News / Politics

By: Katharine Cimmino, Editor-in-Chief – Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a very popular illicit drug.1 According to the National Survey on Drug Use and Health, “In 2012, 5.4 million persons aged 12 or older used marijuana on a daily or almost daily basis in the past 12…

Do You Know Your Organizations?: APhA-ASP...
January 1, 2014 - Events

The mission of the American Pharmacists Association Academy of Student Pharmacists (APhA-ASP) is to be the collective voice of student pharmacists, to provide opportunities for professional growth, to improve patient care, and to envision and advance the future of pharmacy. Our main purpose as a student chapter is to provide means for student pharmacists to…

Direct Association of HIV and Early Kidney Damage in Wo...
January 1, 2014 - Featured , In the News / Politics

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC – Human immunodeficiency virus (HIV) is a global pandemic, with approximately 35.3 million people infected in 2012. The United States currently has 1.3 million people living with HIV, with 20,000 deaths occurring every year due to acquired immune deficiency syndrome…

Do You Know Your Organizations?: Rho Chi...
January 1, 2014 - Events

The Rho Chi Society is an Academic Honor Society in Pharmacy. Pharmacy students in their professional years of study are invited to join based on academic standing. The Mission of the Society is to encourage and recognize excellence in intellectual achievement and foster fellowship amongst its members. Our Beta Delta Chapter at St. John’s University…

Newly Approved: Macitentan (Opsumit®)...
December 1, 2013 - Clinical , Featured

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy – The FDA approved macitentan (Opsumit®) on October 18, 2013 for the treatment of pulmonary arterial hypertension.1 Pulmonary arterial hypertension, often referred to as PAH, is a disease characterized by high blood pressure in the arteries between the heart and lungs. An increase…

Possible Inhaled Option for Diabetics...
December 1, 2013 - In the News / Politics

By: Sang Hyo Kim, Staff Editor – Near the end of December, the pharmaceutical company, MannKind Corp, will submit their clinical data to the U.S Food and Drug Administration for the approval of an inhaled dosage form of insulin, Afrezza®.1 Administered with the Dreamboat inhaler, this inhaled dosage form delivers insulin packaged into single dose…

Ponatinib Taken Off the Market...
December 1, 2013 - In the News / Politics

By: Sherine Jaison, PharmD Candidate c/o 2015 –  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the market. The drug was under investigation by the Food and Drug Administration (FDA) following several reports of serious and life threatening blood clots and narrowing of the blood vessels.1 Ponatinib is a BCR-ABL tyrosine kinase…

Hospital Drug Shortages...
December 1, 2013 - Featured , In the News / Politics

By: Hamid Razaki, PharmD – Drug shortages seen across pharmacies in the United States continue to be an issue in patient care. A drug product shortage is defined as a supply issue that affects how the pharmacy prepares or dispenses a drug product, or that influences patient care when prescribers must use an alternative agent.1…

Still a Long Road Ahead for New Hepatitis C Treatment...
December 1, 2013 - In the News / Politics

By: Ramya Mathew, PharmD Candidate c/o 2015 – Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been researching a new “nuke” for the treatment of Hepatitis C called VX-135. This nucleotide polymerase inhibitor is currently undergoing clinical trials, but the FDA has put the research on a partial hold due to findings…

Expanding a Technician’s Role...
December 1, 2013 - Professional Advice / Opinions

By: Sang Hyo Kim, Staff Editor – Pharmacy, like much of medicine, is constantly changing, and the new changes in pharmacy practice are even happening to technicians. While there were originally no national standards for pharmacy-technician education and training, the American Society of Health-System Pharmacists (ASHP) and the Accreditation Council for Pharmacy Education (ACPE) have…

Possible Mandatory Lung Cancer Screening...
December 1, 2013 - Featured , In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Lung cancer takes away the lives of about 160,000 individuals annually, which is more than a quarter of all cancer deaths.1 The U.S Preventive Service Task Force is now recommending lung cancer screenings for heavy smokers which could save up to 20,000 lives a year (or about 13%…

Provider Status for Pharmacists: Call to Action or Dist...
December 1, 2013 - Featured , In the News / Politics

By: Samantha Schmidt, PharmD Candidate c/o 2014, Palm Beach Atlantic University – The role of pharmacists in healthcare has grown exponentially over the years. Pharmacists now provide advanced patient-centered care services including coordination of medications during transitions of care, comprehensive medication reviews with medication monitoring, chronic disease management, disease education, prevention and wellness services, and…

Meet the President: An Interview with Father Levesque...
December 1, 2013 - Featured , Professional Advice / Opinions

By: Beatrice Popovitz, Staff Editor and Ada Seldin, Staff Editor –       In August 2013, St. John’s University welcomed Rev. Joseph L. Levesque, C.M., former president of Niagara University, into the community as interim president. Fr. Levesque has an elaborate background in Vincentian leadership and higher education, having taught in various religious institutions such…

Middle East Respiratory Syndrome (MERS)...
November 1, 2013 - In the News / Politics

By: Uzma Toppa, PharmD Candidate c/o 2014 – Middle East Respiratory Syndrome, also known as MERS, is a viral respiratory illness caused by a coronavirus called MERS-CoV. It was first reported in humans in Saudi Arabia in 2012. According to the World Health Organization (WHO), from September 2012 to September 2013, there have been a…

Zecuity(TM): Novel Treatment Option for Migraines...
November 1, 2013 - Clinical

By: Arya Mathew, PharmD Candidate c/o 2014 –  About twelve percent of the U.S. population suffers from migraines, affecting adult women three times more than adult men.  Migraines are returning attacks of moderate to severe, throbbing or pulsing pain, usually on one side of the head.  Along with the severe pain, migraine sufferers also experience…

Moving Towards Provider Status: An Interview with Sandr...
November 1, 2013 - Professional Advice / Opinions

By: Hayeon Na, Co-Copy Editor and Sang Hyo Kim, Staff Editor – In Volume 1 Issue1 of the Rho Chi Post, we were honored to have an interview with Sandra Leal, PharmD, MPH, FAPhA, CDE, and Director of Clinical Pharmacy at El Rio Health Center in Tucson, Arizona. She had started a petition to support…

The Third Wheel or the Steering Wheel? Pharmacists on t...
November 1, 2013 - Professional Advice / Opinions

By: Joshua Bliss, PharmD Candidate c/o 2016 – Doctor – a word often utilized by both professionals and the general public alike to describe a physician. “Doctor” finds its origins in the Latin word for “teacher.” The word “physician,” however, carries a more complicated origin. It is derived from Latin’s “physicum,” meaning remedy.1 In Luke…

Ceftriaxone Induced Hemolytic Anemia...
November 1, 2013 - Clinical , Featured

By: Samad Tirmizi, PharmD Candidate c/o 2014 – Hemolytic anemia (HA) is a type of anemia that occurs due to the breakdown of red blood cells. It is classified as intrinsic and extrinsic according to causative factors. Medication induced hemolytic anemia is an example of extrinsic, while genetic predisposition is an intrinsic factor. Drug induced…

Does Moxifloxacin Increase the Risk of Dysglycemia?...
November 1, 2013 - Clinical , Featured

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU – The antibiotic class known as the fluoroquinolones is widely used in both outpatient and inpatient settings. They provide bactericidal effects by inhibiting DNA gyrase and topoisomerase IV enzymes in bacteria. The systemic agents that are most commonly used in clinical practice include ciprofloxacin, levofloxacin,…

Nature’s Remedy… in a More Palatable Dosage Form...
November 1, 2013 - Featured , In the News / Politics

By: Davidta Brown, Staff Editor – Pathogenic bacteria have been enemies to human health for centuries. As recently as last month, the Centers for Disease Control published an 80-page document informing the public about America’s biggest microbial threats. Most of the pathogens on the list exhibit antibacterial resistance. One particular bacterial species, ranked at threat…

What You Should Know About Selecting APPE Rotations...
October 1, 2013 - Professional Advice / Opinions

By: Aleena Cherian, Co-Copy Editor, Graphics Focused – Selecting APPE Rotations You’ve made it past the progression interviews at the end of 2nd year, the White Coat Ceremony, and the mind-boggling compounding and kinetics equations. You’re almost done with those labs and late night D&D study sessions. Now, halfway through the first semester of your…

New Treatment for a Deficiency in Iron-Supplement Thera...
October 1, 2013 - Clinical

By: Davidta Brown, Staff Editor – For the estimated 7.5 million individuals in the United States living with iron deficiency anemia (IDA), there is now a new alternative to iron supplements or time-consuming, repetitive infusions. On July 25, 2013, the FDA approved ferric carboxymaltose injection (Injectafer®) for the treatment of IDA, especially in patients who…

New Drug to Treat HIV-1 Hits the Market...
October 1, 2013 - Clinical , Featured

By: Ada Seldin, Staff Editor – On August 12,2013, a new weapon against HIV-1 infection was added to the existing armada. Dolutegravir, the third integrase strand transfer inhibitor to attain FDA approval, targets a protein essential to HIV replication. HIV-1 is the predominant type of HIV virus, the other being HIV-2, which is endogenous to…

After 15 Years, First New Recombinant Coagulation Facto...
October 1, 2013 - Clinical

By: Tamara Yunusova, Senior Staff Editor – After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor IX (Rixubis) has mounted to the forefront of Hemophilia B drug therapy. The recombinant coagulation factor gained orphan drug approval on June 26, 2013 for routine prophylaxis, control of bleeding episodes, and perioperative management in…

Ketoconazole No More...
October 1, 2013 - Featured , In the News / Politics

By: Hayeon Na, Co-Copy Editor [Content-Focused] – The Food and Drug Administration (FDA) announced on July 26th that oral dosage forms of ketoconazole (Nizoral®) should no longer be prescribed as first-line therapy for any fungal infections.1 The label and indication for oral ketoconazole were updated, and a new medication guide was added. Other dosage forms…

Post navigation

← Older posts
Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post